title: Early estrogen treatment of female zebra finches masculinizes the brain pathway for learned vocalizations.
abstract: Telencephalic nucleus HVC and its two efferent targets, RA and X, play essential roles in the production of complex, learned vocalizations in the male zebra finch. Normal females do not produce these learned vocalizations; HVC, RA, and X are small in volume, and HVC and RA are not synaptically connected. We have shown that estrogen treatment during development causes females to learn and produce male-like vocalizations. This article describes the neural masculinization of these E2 females, replicating and extending the work of others. Female zebra finches were treated with 17 beta-estradiol (E2) at hatching, at 14-22 days of age, or as adults. In adulthood, the volumes of nucleus RA and area X were measured and the efferent projections of nucleus HVC examined using the anterograde tracer PHA-L. Early, sustained E2 treatment caused the greatest increase in the volume of RA and X, the innervation of RA and X by HVC axons, and the masculinization of auditory responses of cells in RA. Treatments that lasted for a shorter period or started later in development resulted in different patterns of partial brain masculinization. E2 treatment in adulthood had no effect on the volume of RA or X or their innervation by HVC. Bilateral lesions of the tracheosyringeal nerves or of HVC had the same effects on the male-typical vocalizations produced by E2 females as they do on the vocalizations produced by males. These results demonstrate that the neural masculinization of telencephalic nuclei induced by E2 treatment sets up a functional circuit in females similar to one in males that enables the learning and production of complex vocalizations.
authors.affiliation: Rockefeller University, New York, New York 10021.
authors.forename: H B
authors.initials: HB
authors.lastname: Simpson
authors.forename: D S
authors.initials: DS
authors.lastname: Vicario
mesh_terms: D000367:Age Factors; D000818:Animals; D001717:Birds / Q000254:growth & development / Q000502:physiology*; D001931:Brain Mapping; D004343:Drug Implants; D004525:Efferent Pathways / Q000502:physiology; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D005072:Evoked Potentials, Auditory; D005260:Female; D007858:Learning / Q000187:drug effects* / Q000502:physiology; D008297:Male; D010835:Phytohemagglutinins; D012727:Sex Characteristics; D013687:Telencephalon / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D014132:Trachea / Q000294:innervation; D014770:Virilism / Q000139:chemically induced / Q000473:pathology; D014828:Vocalization, Animal / Q000187:drug effects* / Q000502:physiology
chemical_list: D004343:Drug Implants; D010835:Phytohemagglutinins; C100156:leukoagglutinins, plants; D004958:Estradiol